BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 853223)

  • 1. Hepatitis B circulating immune complexes. Characterization by radioimmunoprecipitation--PEG assay (RIPEGA).
    Santoro F; Wattre P; Dessaint JP; Capron A
    J Immunol Methods; 1977; 15(3):201-9. PubMed ID: 853223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frequency of antigen associated to hepatitis due to virus B (HBAg) and of antibody (HBAc) in healthy subjects and during of course of acute and chronic hepatitis. Radioimmunologic study].
    Realdi G; Tremolada F; Alberti A; Rigoli A; Diodati G; Visconti M
    Quad Sclavo Diagn; 1975 Jun; 11(2):419-30. PubMed ID: 1223946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new solid phase radioimmunoassay (CLB-RIA) for the detection of hepatitis-B antigen and antibody.
    Duimel WJ; Brummelhuis HG
    Vox Sang; 1975; 29(1):1-14. PubMed ID: 1096470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
    Nydegger UE; Lambert PH; Gerber H; Miescher PA
    J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of the radioimmunoprecipitation-PEG assay (RIPEGA) to quantify circulating antigens in human and experimental schistosomiasis.
    Santoro F; Vandemeulebrouke B; Capron A
    J Immunol Methods; 1978; 24(3-4):229-37. PubMed ID: 722095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of hepatitis B antigen and antibody in hospital patients in Copenhagen.
    Skinhoj P
    Scand J Infect Dis; 1975; 7(2):85-9. PubMed ID: 1179171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between circulating antigens detected by the radioimmunoprecipitation-polyethylene glycol assay (RIPEGA) and C1q-binding immune complexes in human schistosomiasis mansoni.
    Santoro F; Prata A; Silva AE; Capron A
    Am J Trop Med Hyg; 1981 Sep; 30(5):1020-5. PubMed ID: 6974508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating antigens and immune complexes in Schistosoma mansoni-infected rats. Characterization by radioimmunoprecipitation-PEG assay (RIPEGA).
    Santoro F; Capron M; Joseph M; Rousseaux-Prevost R; Capron A
    Clin Exp Immunol; 1978 Jun; 32(3):435-42. PubMed ID: 688695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders.
    Wands JR; Chura CM; Roll FJ; Maddrey WC
    Gastroenterology; 1975 Jan; 68(1):105-12. PubMed ID: 1054319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and clinical evaluation of novel radioimmunoassay for the detection of hepatitis B antigen.
    Valentekovich MN
    Dev Biol Stand; 1975; 30():123-8. PubMed ID: 1204951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B antigen (HBAg) and its antibody (HBAb) in hospital patients.
    Payne RW; Barr A; Wallace J
    J Clin Pathol; 1974 Feb; 27(2):125-9. PubMed ID: 4824990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of the radioimmunoprecipitation-PEG assay (RIPEGA) to detect anti-IgG antibodies.
    Santoro F; Duquesnoy B; Wattre P; Delcambre B; Capron A
    Biomedicine; 1977 Jul; 27(6):230-3. PubMed ID: 907801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of anti-HBAg by solid phase radioimmunoassay using labeled human antibody].
    Schiano G; Ricci G
    Quad Sclavo Diagn; 1975 Jun; 11(2):513-5. PubMed ID: 1223955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of the radioimmunoprecipitation polyethylene glycol assay (RIPEGA) for detection of filarial antigens in serum.
    Hamilton RG; Hussain R; Alexander E; Adkinson NF
    J Immunol Methods; 1984 Mar; 68(1-2):349-66. PubMed ID: 6707481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of hepatitis B immunoglobulin in the Netherlands.
    Reesink HW; Duimel WJ; de Boer JE; van Elven EH; Brummelhuis HG
    Dev Biol Stand; 1975; 30():310-5. PubMed ID: 54274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B antigen and antibody in active chronic hepatitis and other liver diseases in Australia. A multicenter collaborative study.
    Cooksley WG; Powell LW; Mistilis SP; Mackay IR; Barker LF
    Am J Dig Dis; 1975 Feb; 20(2):110-4. PubMed ID: 804811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigations concerning the fixation of hepatitis B-antigen (HBAg) on peripheral lymphocytes and isolated hepatocytes in patients with inflammatory liver diseases. (author's transl)].
    Arnold W; Meyer zum Büschenfelde KH; Hopf U; Kordbarlag C
    Klin Wochenschr; 1975 Mar; 53(5):231-5. PubMed ID: 1152350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus antigen quantitation by radioimmunoassay (RIA) in viral hepatitis and in chronic liver diseases.
    De Ritis F; Gravina E; Squame G
    Acta Hepatogastroenterol (Stuttg); 1975 Feb; 22(1):4-13. PubMed ID: 804225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hepatitis B antigen in circulating immune complexes in acute and chronic hepatitis.
    Carella G; Digeon M; Feldmann G; Jungers P; Drouet J; Bach JF
    Scand J Immunol; 1977; 6(12):1297-304. PubMed ID: 24265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating immune complexes in human sera by simplified assays with polyethylene glycol.
    Digeon M; Laver M; Riza J; Bach JF
    J Immunol Methods; 1977; 16(2):165-83. PubMed ID: 881555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.